NSC001
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for NSC001, covering 2026-04-17 to 2026-04-17. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Assess Safety and Tolerability and to Explore Efficacy of NSC001 in Mild to Moderate Alzheimer's Disease [Phase 1, Phase 2]